Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 4 Prevalence of HFpEF and HFrEF by age

Published byΒαρθολομαίος Δοξαράς Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 4 Prevalence of HFpEF and HFrEF by age"— Presentation transcript:

1 Figure 4 Prevalence of HFpEF and HFrEF by age
and sex in a southwest European community-based cohort Figure 4 | Prevalence of HFpEF and HFrEF by age and sex in a southwest European community-based cohort. a | The prevalence of heart failure with preserved ejection fraction (HFpEF) increased with age in both sexes, but was higher in women at any given age. b | Conversely, the prevalence of heart failure with reduced ejection fraction (HFrEF) increased with age in both sexes, but was higher in men at any given age. Reproduced with permission from Ceia, F. et al. Prevalence of chronic heart failure in southwestern Europe: the EPICA study. Eur. J. Heart Fail. 4 (4), 531–539 (2002). Reproduced with permission from Ceia, F. et al. Prevalence of chronic heart failure in southwestern Europe: the EPICA study. Eur. J. Heart Fail. 4 (4), 531–539 (2002) Dunlay, S. M. et al. (2017) Epidemiology of heart failure with preserved ejection fraction Nat. Rev. Cardiol. doi: /nrcardio

Download ppt "Figure 4 Prevalence of HFpEF and HFrEF by age"

Similar presentations

Age-standardized mortality from ischaemic heart disease in European regions (men; age group 45-74 years; year 2000) J Muller-Nordhorn, et al. Eur Heart.

Age-standardized mortality from ischaemic heart disease in European regions (men; age group years; year 2000) J Muller-Nordhorn, et al. Eur Heart.
Date of download: 11/13/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Reality of Heart Failure in Latin America J.

Date of download: 11/13/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Reality of Heart Failure in Latin America J.
Figure 1 Initial management of a patient with acute heart failure

Figure 1 Initial management of a patient with acute heart failure
Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Prevalence of functional mitral regurgitation according to NYHA functional class (A; P 

Figure 1 Prevalence of functional mitral regurgitation according to NYHA functional class (A; P 
Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.

Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.
Figure 2 Muscle structure

Figure 2 Muscle structure
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Lung and pleural ultrasonography

Figure 1 Lung and pleural ultrasonography
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 10 Assessment of myocardial fibrosis

Figure 10 Assessment of myocardial fibrosis
Reproduced with permission from Yancy, C. W. et al. 2017

Reproduced with permission from Yancy, C. W. et al. 2017
Figure 5 BMI and cardiorespiratory fitness levels

Figure 5 BMI and cardiorespiratory fitness levels
Figure 8 Implanted devices for the management of heart failure

Figure 8 Implanted devices for the management of heart failure
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 BMI and mortality in patients with heart failure

Figure 4 BMI and mortality in patients with heart failure
Figure 1 Old age, metabolites, and chronic inflammation

Figure 1 Old age, metabolites, and chronic inflammation

Similar presentations

Ads by Google